Cerenome (CNSY) Gross Profit Growth (1y) (2012 - 2018)
Powered by 
Analysis
Cerenome (CNSY) Gross Profit Growth (1y) (2012 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 126.09% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 33.01% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 57.16% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 351.57% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 1,250.00% |
| Jun 30, 2018 | -88.55% |
| Mar 31, 2018 | 221.60% |
| Dec 31, 2017 | -94.43% |
| Sep 30, 2017 | -117.70% |
| Jun 30, 2017 | -51.57% |
| Mar 31, 2017 | -116.32% |
| Dec 31, 2016 | -31.90% |
| Sep 30, 2016 | -57.20% |
| Jun 30, 2016 | 70.13% |
| Mar 31, 2016 | 151.15% |
| Dec 31, 2015 | -27.35% |
| Sep 30, 2015 | 45.86% |
| Jun 30, 2015 | 88.17% |
| Mar 31, 2015 | -50.00% |
| Dec 31, 2014 | -33.35% |
| Sep 30, 2014 | -73.58% |
| Jun 30, 2014 | -78.88% |
| Mar 31, 2014 | -4.09% |
| Dec 31, 2013 | -38.16% |